Annovis Bio, Inc.

NYSE:ANVS

1.53 (USD) • At close May 9, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20242023202220212020201920182017
Operating Activities:
Net Income -24,590.375-56.204-25.329-14.487-5.462-0.991-0.714-0.682
Depreciation & Amortization 00000.1291.19100
Deferred Income Tax 0000-0.129-1.19100
Stock Based Compensation 3,836.774.6289.1534.6981.8650.0080.0830.048
Change In Working Capital 0.6822.44-1.1370.657-0.4010.4220.0730.096
Accounts Receivables 00000.735-0.73500
Inventory 0000-0.7350.73500
Accounts Payables 1.01303.2730.346-0.6960.969-0.0030.062
Other Working Capital -0.3312.44-4.410.3110.295-0.5480.0750.035
Other Non Cash Items -1,141.6819.1695.8794.3510.0270.0840.0850.012
Operating Cash Flow -21,894.604-39.967-17.313-9.132-3.971-0.477-0.559-0.537
Investing Activities:
Investments In Property Plant And Equipment 00000000
Acquisitions Net 00000000
Purchases Of Investments 00000000
Sales Maturities Of Investments 00000000
Other Investing Activites 00000000
Investing Cash Flow 00000000
Financing Activities:
Debt Repayment 000000.5300
Common Stock Issued 18.66716.8860.00546.64812.034-0.0790.0030.008
Common Stock Repurchased 00000000
Dividends Paid 00000000
Other Financing Activities 26,673.1330.4580.0050.0950.009-0.0870.490.656
Financing Cash Flow 26,691.817.3440.00546.74412.0440.4430.2460.332
Other Information:
Effect Of Forex Changes On Cash 00000000
Net Change In Cash 4,797.196-22.623-17.30837.6118.073-0.033-0.312-0.205
Cash At End Of Period 10,551.9165.75528.37845.6868.0750.0020.0350.347